thérapie (1) association (1) analyse (1) maladie (1) âge (1) biomarqueur (1) cancer (1) Development (1) Treatment (1) Cancer (1) Inhibitors (1) Methods (1) White (1) Therapeutics (1) Symptoms (1) Social groups (1) Serum (1) Patients (1) Manufacturers' agents (1) Inflammation (1) Immunotherapy (1) Diarrhea (1) Commission merchants (1) Colitis (1) Cancer (1) C-reactive protein (1) Age (1) Methods (1) Infliximab (1) Age (1)